Cara Taheny
Research Subjects
Cara Taheny has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Lipa
AASHM, National Policy and Education Division, Sydney, NSW, Australia
1 shared publication - Beau Newham
National HIV Self‐testing Project, National Association of People With HIV Australia (NAPWHA) Newtown New South Wales Australia
1 shared publication - Brent Allan
Qthink Consulting Melbourne Victoria Australia
1 shared publication - Brent Clifton
National Association of People with HIV Australia (NAPWHA) Newtown New South Wales Australia
1 shared publication Catriona Ooi
JNorthern Sydney Local Health District, Sexual Health Service, St Leonards, NSW, Australia
1 shared publicationDiane Rowling
HMetro North Public Health, Queensland Syphilis Surveillance Service (South), Brisbane, Qld, Australia
1 shared publication
Latest Publications
- 16 June 2026
- Published by CSIRO Publishing in Sexual Health
- Vol. 23 (4)
Priorities to eliminate congenital syphilis in Australia: findings from a national roundtable
Congenital syphilis remains a significant public health threat in Australia, warranting national efforts to reduce syphilis incidence overall, focusing on women of reproductive age. To identify priority actions to eliminate congenital syphilis, ASHM convened a national multidisciplinary roundtable with attendance from organisations, colleges, and bodies across the healthcare sector with a focus on Aboriginal and Torres Strait Islander peoples’ health, sexual and reproductive health, antenatal health, primary care, pathology, and pharmacy, as well as research institutes and community organisations. This position statement outlines the immediate, short-term and long-term actions identified by roundtable participants to eliminate congenital syphilis in Australia.
- 16 June 2026
- Published by CSIRO Publishing in Sexual Health
- Vol. 23 (4)
Priorities to eliminate congenital syphilis in Australia: findings from a national roundtable
Congenital syphilis remains a significant public health threat in Australia, warranting national efforts to reduce syphilis incidence overall, focusing on women of reproductive age. To identify priority actions to eliminate congenital syphilis, ASHM convened a national multidisciplinary roundtable with attendance from organisations, colleges, and bodies across the healthcare sector with a focus on Aboriginal and Torres Strait Islander peoples’ health, sexual and reproductive health, antenatal health, primary care, pathology, and pharmacy, as well as research institutes and community organisations. This position statement outlines the immediate, short-term and long-term actions identified by roundtable participants to eliminate congenital syphilis in Australia.
- 15 August 2025
- Published by Wiley in HIV Medicine
- Vol. 26 (S3) , 3-16
Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable
Introduction: In 2022, Australia met the global UNAIDS 95% targets for treatment and viral suppression. Achieving 95% of people knowing their HIV status requires implementation of a wider mix of HIV testing types and access points.Methods: In October 2023, a community‐led HIV testing roundtable meeting of 34 participants was convened to better understand current barriers and enablers to foster HIV testing equity. Delegates participated in data‐informed discussions and a facilitated workshop. Outputs were collated and independently analysed to identify HIV testing barriers and potential actionable strategies.Results: Current best practices for HIV testing are targeted towards at‐risk populations and limited by funding and capacity constraints. Identified barriers to testing include ongoing stigma, cultural barriers, structural barriers to accessing and navigating the healthcare system, clinical reticence among non‐expert practitioners and the need to expand access beyond at‐risk groups. Current HIV testing practices are limited by a lack of provider‐initiated (opt‐out) testing, contributing to late diagnoses among people with high barriers to testing. Awareness of and access to HIV testing resources need to be expanded and should be underpinned by healthcare education. Wider exploration of opt‐out testing is warranted, but requires consideration of jurisdictional infrastructure/funding differences and determination of optimal settings.Conclusions: To achieve the UNAIDS 95% diagnosis target, we recommend three key strategies: implementing opt‐out testing in selected settings, expanding access to self‐testing and reducing barriers to point of care testing. These strategies should be supported by enhanced healthcare provider education and actions to reduce structural barriers to testing access.
- 15 August 2025
- Published by Wiley in HIV Medicine
- Vol. 26 (S3) , 3-16
Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable
Introduction: In 2022, Australia met the global UNAIDS 95% targets for treatment and viral suppression. Achieving 95% of people knowing their HIV status requires implementation of a wider mix of HIV testing types and access points.Methods: In October 2023, a community‐led HIV testing roundtable meeting of 34 participants was convened to better understand current barriers and enablers to foster HIV testing equity. Delegates participated in data‐informed discussions and a facilitated workshop. Outputs were collated and independently analysed to identify HIV testing barriers and potential actionable strategies.Results: Current best practices for HIV testing are targeted towards at‐risk populations and limited by funding and capacity constraints. Identified barriers to testing include ongoing stigma, cultural barriers, structural barriers to accessing and navigating the healthcare system, clinical reticence among non‐expert practitioners and the need to expand access beyond at‐risk groups. Current HIV testing practices are limited by a lack of provider‐initiated (opt‐out) testing, contributing to late diagnoses among people with high barriers to testing. Awareness of and access to HIV testing resources need to be expanded and should be underpinned by healthcare education. Wider exploration of opt‐out testing is warranted, but requires consideration of jurisdictional infrastructure/funding differences and determination of optimal settings.Conclusions: To achieve the UNAIDS 95% diagnosis target, we recommend three key strategies: implementing opt‐out testing in selected settings, expanding access to self‐testing and reducing barriers to point of care testing. These strategies should be supported by enhanced healthcare provider education and actions to reduce structural barriers to testing access.